-
Adaptive Biotechnologies reports 55% revenue growth in 2025
-
Adaptive Biotechnologies subsidiary raises up to $15 million in series A
-
Adaptive Biotechnologies signs two TCR licensing deals with Pfizer
-
Piper Sandler on Adeptus Biotechnologies Corp. (ADPT): 'Long Case Is Strengthened by Competition'
-
Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 23c
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $20 at Piper Sandler
-
Guggenheim Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
-
BTIG Reiterates Buy Rating on Adeptus Biotechnologies Corp. (ADPT)
-
Piper Sandler Calls Adeptus Biotechnologies (ADPT) 'A Top Pick', Lifts Stock PT
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at Morgan Stanley
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $14 at BTIG
-
Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
-
Craig-Hallum Starts Adeptus Biotechnologies Corp. (ADPT) at Buy
-
Grindr (GRND) appoints Chad Cohen to Board
-
Adaptive Biotechnologies (ADPT) Highlights New Data at 2025 ASCO and EHA 2025
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $11 at BTIG
-
Adaptive Biotechnologies (ADPT) Tops Q1 EPS by 9c
-
Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
-
Goldman Sachs Upgrades Adeptus Biotechnologies Corp. (ADPT) to Buy
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $12 at Scotiabank
-
Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c, provides guidance
-
Adaptive Biotechnologies (ADPT) and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
-
Adeptus Biotechnologies Corp. (ADPT) PT Raised to $9 at BTIG
-
Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 7c ; Offers Guidance
-
Adaptive Biotechnologies (ADPT) Receives Expanded Medicare Coverage of clonoSEQ
-
Goldman Sachs Assumes Adeptus Biotechnologies Corp. (ADPT) at Neutral
-
Piper Sandler Reiterates Overweight Rating on Adeptus Biotechnologies Corp. (ADPT)
-
Adaptive Biotechnologies (ADPT) Announces IVDR Certification for clonoSEQ in European Union
-
Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 2c, updates guidance

